Ji Zengyang, Lu Min, Xie Huanhuan, Yuan Honggang, Chen Qing
Department of Endocrinology, Changxing County Hospital of Traditional Chinese Medicine, Huzhou, Zhejiang 313199, P.R. China.
Biomed Rep. 2022 Jun 29;17(3):72. doi: 10.3892/br.2022.1555. eCollection 2022 Sep.
The etiology of diabetes is primarily attributed to the lack of functioning β cells, which in-turn leads to insulin deficiency or insulin resistance, and this ultimately leads to β cell dysfunction. Restoring the number and function of β cells is an effective means of improving or even curing diabetes. β cell regeneration is a potential method for increasing the number of functioning β cells. In addition to self-duplication of pancreatic β cells, β cells can be regenerated from embryonic stem cells, human induced pluripotent stem cells and pancreatic stem cells. Based on these mechanisms, proliferation and differentiation into functional β cells is one of the most promising strategies for treatment of diabetes. Although β cell regeneration has significant potential in the treatment of insulin-deficient diabetes, and significant progress has been made in this regard, there remains challenges which prevent its use in the clinic.
糖尿病的病因主要归因于功能性β细胞的缺乏,这进而导致胰岛素缺乏或胰岛素抵抗,最终导致β细胞功能障碍。恢复β细胞的数量和功能是改善甚至治愈糖尿病的有效手段。β细胞再生是增加功能性β细胞数量的一种潜在方法。除了胰腺β细胞的自我复制外,β细胞还可以从胚胎干细胞、人诱导多能干细胞和胰腺干细胞再生而来。基于这些机制,增殖并分化为功能性β细胞是治疗糖尿病最有前景的策略之一。尽管β细胞再生在治疗胰岛素缺乏型糖尿病方面具有巨大潜力,并且在这方面已经取得了重大进展,但仍然存在一些挑战,阻碍了其在临床上的应用。